Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 204763
Company: NOVEL LABS INC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CARBIDOPA CARBIDOPA 25MG TABLET;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
10/20/2017 ORIG-1 Approval STANDARD

Label is not available on this site.

CARBIDOPA

TABLET;ORAL; 25MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CARBIDOPA CARBIDOPA 25MG TABLET;ORAL Prescription No AB 204291 ALVOGEN
CARBIDOPA CARBIDOPA 25MG TABLET;ORAL Prescription No AB 203261 AMERIGEN PHARMS LTD
CARBIDOPA CARBIDOPA 25MG TABLET;ORAL Prescription No AB 211055 AUROBINDO PHARMA LTD
CARBIDOPA CARBIDOPA 25MG TABLET;ORAL Prescription No AB 205304 EDENBRIDGE PHARMS
CARBIDOPA CARBIDOPA 25MG TABLET;ORAL Prescription No AB 204763 NOVEL LABS INC
CARBIDOPA CARBIDOPA 25MG TABLET;ORAL Prescription No AB 209910 ZYDUS PHARMS
LODOSYN CARBIDOPA 25MG TABLET;ORAL Prescription Yes AB 017830 ATON

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English